Limited efficacy of pentoxifylline as anti-inflammatory agent in experimental pneumococcal meningitis

Clinical and Experimental Immunology

Volumn 107, Issue 3, 1997, Pages 458-461

  Zysk, G ^a   Bruck W ^a   Fischer, F R ^a   Mader M ^a   Rieckmann, P ^b   Nau, R ^a,c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Cytokines; Damage; Immunomodulation; Neuronal; Pentoxifylline; Pneumococcal meningitis

Indexed keywords

ANTIINFLAMMATORY AGENT; CEFTRIAXONE; LACTIC ACID; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID; CONTROLLED STUDY; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; RABBIT; STREPTOCOCCUS PNEUMONIAE;

EID: 0031054605     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-949.x     Document Type: Article

References (25)

1. Tuomanen E, Hengstler B, Rich R, Bray MA, Zak O. Non-steroidal anti-inflammatory therapy for experimental pneumococcal meningitis. J Infect Dis 1987; 155:985-90.
2. Täuber MG, Shibl AM, Hackbarth CJ, Larrick JW, Sande MA. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits. J Infect Dis 1987; 156:456-62.
3. Mustafa MM, Mertsola J, Ramilo O, Sáez-Llorens X, Risser RC, McCracken GH. Increased endotoxin and interleukin-1β concentrations in cerebrospinal fluid of infants with coliform meningitis and ventriculitis associated with intraventricular gentamicin therapy. J Infect Dis 1989; 160:891-5.
4. Sáez-Llorens X, Jafari HS, Severien C et al. Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis. J Clin Invest 1991; 88:2003-11.
5. Mustafa MM, Ramilo O, Mertsola J et al. Modulation of inflammation and cachectin activity in relation to treatment of experimental Haemophilus influence type b meningitis. J Infect Dis 1989; 160:818-25.
6. Odio CM, Faingezicht I, Paris M et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991; 324:1525-31.
7. Kanra GY, Özen H, Seçmeer G, Ceyhan M, Ecevit Z, Belgin E. Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatr Infect Dis J 1995; 14:490-4.
8. Cabellos C, Martinez-Lacasa J, Martos A et al. Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis. Antimicrob Agents Chemother 1995; 39:2158-60.
9. Paris MM, Hickey SM, Uscher MI, Shelton S, Olsen KD, McCracken GH Jr. Effect of dexamethasone on experimental penicillin- and cephalosporine-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1994; 38:1320-4.
10. Bradley JS. Dexamethasone therapy in meningitis: potentially misleading antiinflammatory effects in central nervous system infections. Pediatr Infect Dis J 1994; 13:823-6.
11. Zysk G, Brück W, Gerber J, Brück Y, Prange HW, Nau R. Antiinflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. J Neuropathol Exp Neurol 1996; 55:722-8.
12. Sáez-Llorens X, Ramilo O, Mustafa MM et al. Modulation of meningeal inflammation by treatment with pentoxifylline. Pediatr Infect Dis J 1989; 8:922-3.
13. Sáez-Llorens X, Ramilo O, Mustafa MM et al. Pentoxifylline modulates meningeal inflammation in experimental bacterial meningitis. Antimicrob Agents Chemother 1990; 34:837-43.
14. Strieter RM, Remick DG, Ward PA et al. Cellular and molecular regulation of tumor necrosis factor alpha production by pentoxifylline. Biochem Biophys Res Commun 1988; 155:1230-6.
15. Hadjiminas DJ, McMasters KM, Robertson SE, Cheadle WG. Enhanced survival from cecal ligation and puncture with pentoxifylline is associated with altered neutrophil trafficking and reduced interleukin-1-beta expression but not inhibition of tumor necrosis factor synthesis. Surgery 1994; 116:348-55.
16. Täuber MG, Burroughs M, Niemöller UM, Küster H, Borschberg U, Tuomanen E. Differences of pathophysiology in experimental meningitis caused by three strains of Streptococcus pneumoniae. J Infect Dis 1991; 163:806-11.
17. Mathison JC, Wolfson E, Ulevitch RJ. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest 1988; 81:1925-37.
18. Chalkiadakis GE, Kostakis A, Karayannakos PE et al. Pentoxifylline in the treatment of experimental peritonitis in rats. Arch Surg 1985; 120:1141-4.
19. Ishizaka A, Zhaohan WV, Stephens KE et al. Attenuation of acute lung injury in septic guinea pigs by pentoxifylline. Am Rev Respir Dis 1988; 138:176-82.
20. Schonharting MM, Schade UF. The effect of pentoxifylline in septic schock. New pharmacologie aspects of an established drug. J Med (Westbury) 1989; 20:97-105.
21. Kudoh I, Ohtake M, Nishizawa H et al. The effect of pentoxifylline on acid-induced alveolar epithelial injury. Anesthesiology 1995; 82:531-41.
22. Lockemeyer MR, Smith CV. Analysis of pentoxifylline in rabbit plasma using a Hisep™ high-performance liquid chromatography column. J Chromatography 1990; 532:162-7.
23. Beermann B, Ings R, Mansby J, Chamberlain J, McDonald A. Kinetics of intravenous and oral pentoxifylline in healthy subjects. Clin Pharmacol Ther 1985; 37:25-28.
24. Ward A, Clissold SP. Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 1987; 34:50-97.
25. Inoue S, Takahashi H, Kaneko KI. The fluctuation of neuron-specific enolase (NSE) levels of cerebrospinal fluid during bacterial meningitis: the relationship between the fluctuations of NSE levels and neurological complications or outcome. Acta Paediatrica Japonica 1994; 36:485-8.